Centogene – Healthcare Data News

CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders

CAMBRIDGE, Mass., ROSTOCK, Germany and BERLIN, April 11, 2023 (GLOBE NEWSWIRE) — Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced...

February 21, 2023February 27, 2023 Competitor News

In the Lead-Up to Rare Disease Day, CENTOGENE Expands Observational Study to Advance the Genetic Understanding of Frontotemporal Dementia (FTD)

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Feb. 21, 2023 (GLOBE NEWSWIRE) — Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers in rare and neurodegenerative diseases,...

November 3, 2022November 4, 2022 Collaborations Competitor News Data Partnership

CENTOGENE Launches Rare and Neurodegenerative Disease Biodata Network

November 03, 2022 06:00 ET | Source: Centogene NV CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Nov. 03, 2022 (GLOBE NEWSWIRE) — Centogene N.V. (Nasdaq: CNTG), the essential life science partner for...

June 13, 2022June 16, 2022 Collaborations Competitor News Data Partnership

CENTOGENE and Agios Expand Partnership for Clinical Development of PYRUKYND® (mitapivat) to Treat Children With Rare Blood Disease

Working together on the world’s first treatment that targets the underlying causes of pyruvate kinase (“PK”) deficiency in children under the age of 18 June 13, 2022 06:30 ET | Source: Centogene...

April 29, 2022 Collaborations Competitor News Data Partnership

CENTOGENE and Takeda Extend Market Access and Expansion Partnership to Advance Patient Care Globally

April 28, 2022 06:30 ET | Source: Centogene NV Accelerating the path from diagnosis to available treatments for rare metabolic and rare neurodegenerative diseases CENTOGENE and Takeda extend contract to continue providing...

March 17, 2022March 21, 2022 Collaborations Competitor News Data Partnership

CENTOGENE Announces Expansion of Data Access and Collaboration Agreement With Pfizer

March 17, 2022 06:30 ET | Source: Centogene NV In November 2019, CENTOGENE first announced the signing of a data access and collaboration agreement to discover and validate novel genetic and biochemical...